| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-11-12 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-10-30 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Aurobindo Pharma Limited | 2026-10-07 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | 2026-09-18 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2026-09-14 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2026-09-14 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-09-09 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV), for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2026-07-29 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2026-07-08 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-07-07 |
| These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2026-07-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Major Pharmaceuticals | 2026-05-21 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2026-04-20 |
| These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Janssen Products LP | AMPAC Fine Chemicals | Gilead Alberta ULC | Patheon, Inc. | Evonik Operations GmbH | Janssen Pharmaceutica NV | Union Quimico Farmaceutica SA (Uquifa) | Janssen Cilag SpA | Esteve Quimica, SA | Yuhan Chemical, Inc. | Janssen Ortho LLC | Janssen Pharmaceuticals, Inc. | Janssen Pharmaceutical Sciences Unlimited Company | Porton Pharma Solutions Ltd | Thermo Fisher Scientific Cork Limited | 2026-04-17 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-03-30 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Major Pharmaceuticals | 2026-03-13 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2026-03-12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Bryant Ranch Prepack | 2026-03-10 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2026-03-05 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. GILEAD ACCESS PROGRAM VIREAD™ (tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2001 | Product name | Gilead Sciences, Inc. | 2026-02-13 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2026-02-12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Proficient Rx LP | 2026-02-01 |
| TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | AvKARE | 2026-01-15 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | 2026-01-12 |
| Tenofovir Disoproxil Fumarate Tablets Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval Date: 2001 | Product name | AvPAK | 2026-01-09 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Strides Pharma Science Limited | Strides Pharma Global Pte. Ltd. | 2026-01-08 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Strides Pharma Science Limited | 2026-01-05 |
| Lamivudine Oral Solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Product name | Chartwell Govermental & Specialty RX, LLC. | 2026-01-02 |
| LAMIVUDINE oral solution These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution Initial U.S. Approval: 1995 | Product name | Chartwell RX, LLC | 2025-12-30 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Major Pharmaceuticals | 2025-12-24 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug | 2025-12-13 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug | 2025-12-02 |
| These highlights do not include all the information needed to use ODEFSEY safely and effectively. See full prescribing information for ODEFSEY. ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2016 | Product name | Gilead Sciences, Inc. | 2025-12-02 |
| LAMIVUDINE TABLETS. These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Golden State Medical Supply, Inc. | 2025-11-24 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Bryant Ranch Prepack | 2025-11-04 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-10-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2025-10-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2025-10-29 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2025-10-29 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2025-10-17 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2025-10-17 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | PD-Rx Pharmaceuticals, Inc. | 2025-10-09 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Bryant Ranch Prepack | 2025-09-29 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2025-09-19 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2025-08-20 |
| LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Golden State Medical Supply, Inc. | 2025-08-12 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | Product name | Strides Pharma Science Limited | 2025-08-02 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Gilead Sciences, Inc. | 2025-07-30 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2025-07-28 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Major Pharmaceuticals | 2025-07-18 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2011 | Product name | Gilead Sciences, Inc. | 2025-07-16 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2011 | Product name | Gilead Sciences, Inc. | 2025-07-16 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Product name | Gilead Sciences, Inc | 2025-07-16 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | Product name | Gilead Sciences, Inc | 2025-07-16 |
| These highlights do not include all the information needed to use VEMLIDY safely and effectively. See full prescribing information for VEMLIDY. VEMLIDY ® (tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-07-14 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval: 2004 | Product name | AvKARE | 2025-07-01 |
| These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-06-20 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Apotex Corp. | Apotex Inc. | 2025-06-17 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Product name | Merck Sharp & Dohme LLC | 2025-06-12 |
| These highlights do not include all the information needed to use ABACAVIR and LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR and LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-05-31 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2025-04-18 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 2025-04-14 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Strides Pharma Science Limited | 2025-03-27 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR AND LAMIVUDINE TABLETS, for oral use Initial U.S. Approval: 2004 | Product name | Macleods Pharmaceuticals Limited | 2025-03-03 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Macleods Pharmaceuticals Limited | 2025-03-03 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 2001 | Product name | Gilead Sciences, Inc. | 2025-02-18 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Florida Pharmaceutical Products, LLC. | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 2025-02-11 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS, safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Coupler LLC | Strides Pharma Science Limited | 2025-02-06 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Product name | Gilead Sciences, Inc. | 2025-02-04 |
| These highlights do not include all the information needed to use GENVOYA safely and effectively. See full prescribing information for GENVOYA. GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Product name | Gilead Sciences, Inc. | 2025-02-03 |
| Emtricitabine/TDF | Product name | Direct_Rx | 2025-01-22 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Product name | DirectRx | 2025-01-21 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Quinn Pharmaceuticals | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 2025-01-10 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 2025-01-09 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-01-09 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE Tablets Initial U.S. Approval: 1995 | Product name | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 2025-01-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals, Inc. | 2024-12-26 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Product name | Mylan Pharmaceuticals Inc. | 2024-12-14 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | Product name | Strides Pharma Science Limited | 2024-12-12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | APPCO PHARMA LLC | 2024-12-05 |
| Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | Product name | Zydus Lifesciences Limited | 2024-11-28 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2024-10-16 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | PD-Rx Pharmaceuticals, Inc. | 2024-10-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Product name | Proficient Rx LP | 2024-10-01 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Teva Pharmaceuticals USA, Inc. | 2024-09-30 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | American Health Packaging | 2024-09-16 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral use EPIVIR (lamivudine) oral solution Initial U.S. Approval: 1995 | Product name | ViiV Healthcare Company | 2024-08-15 |
| These highlights do not include all the information needed to use EPIVIR safely and effectively. See full prescribing information for EPIVIR. EPIVIR (lamivudine) tablets, for oral use EPIVIR (lamivudine) oral solution Initial U.S. Approval: 1995 | Product name | ViiV Healthcare Company | 2024-08-15 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | Product name | RedPharm Drug, Inc. | RedPharm Drug | 2024-08-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | LUPIN LIMITED | 2024-08-07 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | 2024-08-07 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | A-S Medication Solutions | 2024-08-05 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug | 2024-07-24 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Redpharm Drug, Inc. | Zydus Pharmaceuticals USA Inc. | 2024-07-18 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Product name | NuCare Pharmaceuticals,Inc. | 2024-07-16 |
| RedPharm Drug, Inc. human prescription drug label | Product name | RedPharm Drug, Inc. | 2024-07-15 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2024-07-08 |
| These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014 | Product name | ViiV Healthcare Company | 2024-07-08 |
| These highlights do not include all the information needed to use EFAVIRENZ safely and effectively. See full prescribing information for EFAVIRENZ TABLETS EFAVIRENZ tablets, for oral use Initial U.S. Approval: 1998 | Product name | Macleods Pharmaceuticals Limited | 2024-06-28 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS . EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Mylan Pharmaceuticals Inc. | 2024-06-10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | QUALLENT PHARMACEUTICALS HEALTH LLC | Aurobindo Pharma Limited | 2024-06-09 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Aurobindo Pharma Limited | 2024-06-09 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Aurobindo Pharma Limited | 2024-06-07 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Product name | Teva Pharmaceuticals USA, Inc. | 2024-05-28 |
| These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Aurobindo Pharma Limited | 2024-05-24 |
| These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR AND LAMIVUDINE TABLETS. ABACAVIR and LAMIVUDINE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Aurobindo Pharma Limited | 2024-05-19 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | A-S Medication Solutions | 2024-05-16 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Product name | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2024-05-10 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Product name | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 2024-05-07 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Product name | A-S Medication Solutions | 2024-04-30 |
| These highlights do not include all the information needed to use LAMIVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE TABLETS. LAMIVUDINE tablets, for oral use Initial U.S. Approval: 1995 | Product name | Aurobindo Pharma Limited | 2024-04-29 |
| These highlights do not include all the information needed to use DOVATO safely and effectively. See full prescribing information for DOVATO. DOVATO (dolutegravir and lamivudine) tablets, for oral use Initial U.S. Approval: 2019 | Product name | ViiV Healthcare Company | 2024-04-18 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Product name | Aurobindo Pharma Limited | 2024-04-16 |
| These highlights do not include all the information needed to use LAMIVUDINE ORAL SOLUTION safely and effectively. See full prescribing information for LAMIVUDINE ORAL SOLUTION. LAMIVUDINE oral solution, for oral use Initial U.S. Approval: 1995 | Product name | Rising Pharma Holdings, Inc. | Aurobindo Pharma Limited | 2024-04-16 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Product name | Golden State Medical Supply, Inc. | 2024-04-08 |
| These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | Product name | Bryant Ranch Prepack | 2024-04-05 |
| These highlights do not include all the information needed to use EFAVIRENZ TABLETS safely and effectively. See full prescribing information for EFAVIRENZ TABLETS. EFAVIRENZ tablets, for oral use Initial U.S. Approval: 1998 | Product name | Cipla USA Inc. | CIPLA LIMITED GOA | 2024-03-31 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Product name | Strides Pharma Inc. | 2024-03-18 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Product name | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED KURKUMBH | 2024-03-06 |
| Tenofovir Disoproxil Fumarate Tablets Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval Date: 2001 | Product name | AvPAK | 2024-01-08 |